C4b-binding protein (C4BP) is a major regulatory molecule of the complement system. By forming a non covalent complex with the anticoagulant cofactor protein S (PS), it also plays an important role in blood coagulation. C4BP is composed of one beta-chain and seven alpha-chains that are essentially built from complement control protein (CCP)-modules. Our group has previously reported that the first (N-terminal) CCP module of the beta-chain (betaCCP1) contains the entire binding site for protein S. We now investigate further the binding of protein S to C4BP and show that the complex formation is essentially dependent on hydrophobic forces with minor contribution from electrostatic interactions. This result is in agreement with homology modeling experiments carried out in conjunction with inter-species sequence comparison and theoretical enumeration of potential binding sites. These methods pinpoint a solvent exposed hydrophobic cluster at the surface of the betaCCP1 module that is of crucial importance for the binding process.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0167-4838(98)00178-2 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Survival of Strain B31 in Human Serum Is Not Dependent on C4BP Binding to the Bacterial Surface.
Pathogens
November 2024
Department of Clinical Microbiology, Umeå University, 901 87 Umeå, Sweden.
Lyme disease is a vector-borne illness caused by spirochetes belonging to the species group. These bacteria employ several mechanisms to survive within the vertebrate host, including evasion of the complement system. In this study, we examine the protection against human serum killing by the binding of host complement regulators C4b-binding protein (C4BP) and factor H (FH) to the bacterial surface of .
View Article and Find Full Text PDFBiophysical characterization and structural insights of leptospiral complement regulator-acquiring protein A.
Biochem Biophys Res Commun
December 2024
Laboratory of Structural Biology, Department of Biochemistry, School of Life Sciences, University of Hyderabad, Prof. CR Rao Road, Gachibowli, Hyderabad, Telangana, 500046, India. Electronic address:
Many pathogens establish a successful infection by evading the host complement system, an essential arm of innate immunity. Pathogenic Leptospira is reported to escape complement-mediated killing by recruiting the host complement regulators by lipoproteins or outer surface proteins. One of the outer surface proteins, Leptospiral complement regulator-acquiring protein A (LcpA), is known to recruit complement regulators, C4b-binding protein (C4BP), and Factor H (FH) on the bacterial surface.
View Article and Find Full Text PDFC4b-Binding Protein and Factor H Attenuate NLRP3 Inflammasome-Mediated Signalling Response during Group A Streptococci Infection in Human Cells.
J Innate Immun
December 2024
Department of Translational Medicine, Lund University, Malmö, Sweden.
Introduction: Streptococcus pyogenes (group A streptococcus; GAS) is a pathogen causing over half a million deaths annually worldwide. Human immune cells respond to GAS infection by activating the NLRP3 inflammasome leading to the release of pro-inflammatory cytokines that control infection. We investigated the role of C4b-binding protein (C4BP) and factor H (FH) in the inflammasome response to GAS, as they are recruited by GAS to prevent complement deposition and limit phagocytosis.
View Article and Find Full Text PDFA surface lipoprotein on binds complement factor I to promote immune evasion.
bioRxiv
October 2024
Department of Biochemistry, University of Toronto, Toronto, ON, Canada.
is the leading cause of wound infections in humans following animals' bites or scratches. This bacterium is also commonly found in the respiratory tract of many mammals and can cause serious diseases resulting in the brutal rapid death of infected animals, especially cattle. To prevent these infections in cattle, a subunit-based vaccine utilizing the surface lipoprotein PmSLP was developed and showed remarkable protection with a single dose administration.
View Article and Find Full Text PDFFunctional evaluation of rare variants in complement factor I using a minigene assay.
Front Immunol
September 2024
Molecular Otolaryngology and Renal Research Laboratory, Carver College of Medicine, University of Iowa, Iowa City, IA, United States.
The regulatory serine protease, complement factor I (FI), in conjunction with one of its cofactors (FH, C4BP, MCP, or CR1), plays an essential role in controlling complement activity through inactivation of C3b and C4b. The functional impact by missense variants in the gene, particularly those with minor allele frequencies of 0.01% to 0.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!